Jinja Regional Referral Hospital, commonly known as Jinja Hospital, is a hospital in the city of Jinja, in the Eastern Region of Uganda. It is the largest hospital in eastern Uganda, with a bed capacity of 600, although many more patients are admitted, with many sleeping on the floor.

There are 600 beds in Jinja Regional Referral Hospital.

During the past decade, Jinja Regional Referral Hospital conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Jinja Regional Referral Hospital" #1 sponsor was "Liverpool School of Tropical Medicine" with 2 trials, followed by "University of Alberta" with 2 trials sponsored, "Imara, Inc." with 1 trials sponsored, "London School of Hygiene and Tropical Medicine" with 1 trials sponsored and "Neopenda, PBC" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Jinja Regional Referral Hospital" #1 collaborator was "Makerere University" with 5 trials as a collaborator, "Global Health Uganda LTD" with 2 trials as a collaborator, "Kenya Medical Research Institute" with 2 trials as a collaborator, "University of Toronto" with 2 trials as a collaborator and "Indiana University" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "Jinja Regional Referral Hospital" are "Malaria" (2 trials), "Critical Illness" (1 trials), "Death; Neonatal" (1 trials), "Fever" (1 trials) and "Hypothermia, Newborn" (1 trials). Many other conditions were trialed in "Jinja Regional Referral Hospital" in a lesser frequency.

Most popular intervention types in "Jinja Regional Referral Hospital" are "Drug" (4 trials), "Device" (3 trials), "Other" (2 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.

The name of intervention was led by "Diagnostic and prognostic biomarkers" (1 trials), "Dihydroartemisinin Piperaquine" (1 trials), "Emergency Triage and Treatment (ETAT) guidelines" (1 trials), "IMR-687" (1 trials) and "Inhaled Nitric Oxide" (1 trials). Other intervention names were less common.

The vast majority of trials in "Jinja Regional Referral Hospital" are 9 trials for "All" genders.

Currently, there are NaN active trials in "Jinja Regional Referral Hospital". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Jinja Regional Referral Hospital, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Jinja Regional Referral Hospital, 1 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".

Jinja Regional Referral Hospital has several departments that took part in Clinical trials: "Mulago Hospital Sickle Cell Clinic" - 2 trials